My bioparkWELCOME TO BIOPARK
What's in
the news ?
RUE ClÉMENT ADER, 10 6041 CHARLEROI
+32 71 91 99 50
News
Back
GMP certification for Exothera further extends its viral vector manufacturing capacity
March 23rd 2022
BSCB Dev
Exothera S.A., a CDMO specialized in the development and manufacture of viral vectors for vaccines and gene therapies, received Good Manufacturing Practices (GMP) certification from the Federal Agency for Medicines and Health Products (FAMHP) for its facilities in Jumet, Belgium. This accreditation follows a series of successful inspections ensuring that Exothera can manufacture biopharmaceuticals products according to the highest quality standards. This will enable Exothera to extend its services to more customers, supporting biopharma companies from the early development of biotherapeutic candidate to full scale manufacture.
Copyright : D.R
Read Pdf